Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial
Jump to section
Related Articles
Cited By...
- Effect of cumulative dexamethasone dose in preterm infants on neurodevelopmental and growth outcomes: a Western Australia experience
- Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies
- Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
- Postnatal steroids: still a dilemma for neonatologists and parents?
- Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence
- Assessment of myocardial function in preterm infants with chronic lung disease using tissue Doppler imaging
- Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby
- Current UK practices in steroid treatment of chronic lung disease
- NICU Bedside Caregivers Sustain Process Improvement and Decrease Incidence of Bronchopulmonary Dysplasia in Infants < 30 Weeks Gestation
- Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia
- Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15-year experience in Victoria, Australia
- Budesonide Therapy in Preterm Infants to Prevent Bronchopulmonary Dysplasia
- Open-Label Glucocorticoids Modulate Dexamethasone Trial Results in Preterm Infants
- Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
- Oral continuous positive airway pressure (CPAP) following nasal injury in a preterm infant
- How has research in the last 5 years changed my clinical practice?
- Medicines used in respiratory diseases only seen in children
- Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia
- Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants
- Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials
- Effects of Neonatal Dexamethasone Treatment on the Cardiovascular Stress Response of Children at School Age
- Difficult extubation in low birthweight infants
- Effect of a Short Course of Prednisolone in Infants With Oxygen-Dependent Bronchopulmonary Dysplasia
- Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up
- Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
- The DART Study of Low-Dose Dexamethasone Therapy
- Follow-up of a Randomized, Placebo-Controlled Trial of Dexamethasone to Decrease the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Neurodevelopmental Outcomes at 4 to 11 Years of Age
- The DART Study of Low-Dose Dexamethasone Therapy: In Reply
- Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasonef
- Minimising neonatal brain injury: how research in the past five years has changed my clinical practice
- Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants
- Physiological Doses of Corticosteroids for Premature Infants
- Reopening the Debate on Corticosteroids: In Reply
- Reopening the Debate on Corticosteroids: In Reply
- Reopening the Debate on Corticosteroids: To the Editor
- Reopening the Debate on Corticosteroids: To the Editor